JP2023500408A5 - - Google Patents
Info
- Publication number
- JP2023500408A5 JP2023500408A5 JP2022527081A JP2022527081A JP2023500408A5 JP 2023500408 A5 JP2023500408 A5 JP 2023500408A5 JP 2022527081 A JP2022527081 A JP 2022527081A JP 2022527081 A JP2022527081 A JP 2022527081A JP 2023500408 A5 JP2023500408 A5 JP 2023500408A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- compound according
- disease
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025126773A JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962934293P | 2019-11-12 | 2019-11-12 | |
| US62/934,293 | 2019-11-12 | ||
| PCT/US2020/060180 WO2021097057A1 (en) | 2019-11-12 | 2020-11-12 | 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient cftr activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126773A Division JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500408A JP2023500408A (ja) | 2023-01-05 |
| JP2023500408A5 true JP2023500408A5 (https=) | 2023-11-20 |
| JP7721517B2 JP7721517B2 (ja) | 2025-08-12 |
Family
ID=73740547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022527081A Active JP7721517B2 (ja) | 2019-11-12 | 2020-11-12 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
| JP2025126773A Pending JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126773A Pending JP2025160375A (ja) | 2019-11-12 | 2025-07-30 | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240002374A1 (https=) |
| EP (1) | EP4058439A1 (https=) |
| JP (2) | JP7721517B2 (https=) |
| KR (1) | KR20220115829A (https=) |
| CN (1) | CN115003659B (https=) |
| AU (1) | AU2020384279A1 (https=) |
| BR (1) | BR112022009185A2 (https=) |
| CA (1) | CA3158057A1 (https=) |
| CL (1) | CL2022001245A1 (https=) |
| CO (1) | CO2022007953A2 (https=) |
| EC (1) | ECSP22046050A (https=) |
| IL (1) | IL292966A (https=) |
| JO (1) | JOP20220105A1 (https=) |
| MX (1) | MX2022005809A (https=) |
| PE (1) | PE20221461A1 (https=) |
| PH (1) | PH12022551139A1 (https=) |
| WO (1) | WO2021097057A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019222758B2 (en) | 2018-02-15 | 2022-07-07 | Vertex Pharmaceuticals Incorporated | Macrocycles as modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions thereof, their use in the treatment of cystic fibrosis, and process for making them |
| TWI848092B (zh) | 2019-04-03 | 2024-07-11 | 美商維泰克斯製藥公司 | 囊腫纖維化跨膜傳導調節蛋白調節劑 |
| TWI867024B (zh) | 2019-08-14 | 2024-12-21 | 美商維泰克斯製藥公司 | 囊腫纖維化跨膜傳導調節蛋白之調節劑 |
| CA3150162A1 (en) | 2019-08-14 | 2021-02-18 | Vertex Pharmaceuticals Incorporated | Crystalline forms of cftr modulators |
| TWI899097B (zh) | 2019-08-14 | 2025-10-01 | 美商維泰克斯製藥公司 | 製備cftr調節劑之方法 |
| EP4058434A1 (en) | 2019-11-12 | 2022-09-21 | Genzyme Corporation | 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity |
| WO2022076628A1 (en) * | 2020-10-07 | 2022-04-14 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
| AU2021397294A1 (en) | 2020-12-10 | 2023-07-06 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
| CN113480416B (zh) * | 2021-07-12 | 2023-03-21 | 重庆大学 | 一种芳基酮的制备方法 |
| KR20240168370A (ko) | 2022-03-30 | 2024-11-29 | 이시하라 산교 가부시끼가이샤 | 피리다지논계 화합물 또는 그의 염 및 그들을 함유하는 유해 생물 방제제 |
| CN114835655A (zh) * | 2022-04-14 | 2022-08-02 | 河南师范大学 | 一种合成光学活性三氟甲基丙烯酸酯类化合物的方法 |
| EP4611742A1 (en) | 2022-10-31 | 2025-09-10 | Sionna Therapeutics Inc. | Methods of treating cftr-mediated diseases or disorders |
| WO2025017207A1 (en) * | 2023-07-20 | 2025-01-23 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Inhibitors of smndc1 and their therapeutic use |
| WO2025076235A1 (en) | 2023-10-04 | 2025-04-10 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992015570A1 (en) * | 1991-03-07 | 1992-09-17 | Hisamitsu Pharmaceutical Co., Inc. | Novel diphenylthyazole derivative |
| US5856347A (en) * | 1994-11-29 | 1999-01-05 | Hisamitsu Pharmaceutical Co., Inc. | Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof |
| JP2005510508A (ja) * | 2001-11-08 | 2005-04-21 | 藤沢薬品工業株式会社 | アデノシンアンタゴニストとしてのチアゾールピリダジノン類 |
| ZA200602755B (en) | 2003-09-06 | 2007-06-27 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
| RU2014100111A (ru) | 2011-06-10 | 2015-07-20 | МЕДИММЬЮН, ЭлЭлСи | МОЛЕКУЛЫ, СВЯЗЫВАЮЩИЕСЯ С Psl Pseudomonas, И ПУТИ ИХ ПРИМЕНЕНИЯ |
| WO2016183173A1 (en) * | 2015-05-12 | 2016-11-17 | Avista Pharma Solutions | Antiparasitic compounds |
| US10138227B2 (en) * | 2016-06-03 | 2018-11-27 | Abbvie S.Á.R.L. | Heteroaryl substituted pyridines and methods of use |
| TW201811766A (zh) * | 2016-08-29 | 2018-04-01 | 瑞士商諾華公司 | N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途 |
| EP4611742A1 (en) * | 2022-10-31 | 2025-09-10 | Sionna Therapeutics Inc. | Methods of treating cftr-mediated diseases or disorders |
-
2020
- 2020-11-12 CN CN202080092755.2A patent/CN115003659B/zh active Active
- 2020-11-12 BR BR112022009185A patent/BR112022009185A2/pt unknown
- 2020-11-12 MX MX2022005809A patent/MX2022005809A/es unknown
- 2020-11-12 AU AU2020384279A patent/AU2020384279A1/en active Pending
- 2020-11-12 JP JP2022527081A patent/JP7721517B2/ja active Active
- 2020-11-12 KR KR1020227019502A patent/KR20220115829A/ko active Pending
- 2020-11-12 PH PH1/2022/551139A patent/PH12022551139A1/en unknown
- 2020-11-12 IL IL292966A patent/IL292966A/en unknown
- 2020-11-12 WO PCT/US2020/060180 patent/WO2021097057A1/en not_active Ceased
- 2020-11-12 CA CA3158057A patent/CA3158057A1/en active Pending
- 2020-11-12 PE PE2022000772A patent/PE20221461A1/es unknown
- 2020-11-12 EP EP20820656.5A patent/EP4058439A1/en active Pending
-
2022
- 2022-05-10 JO JOP/2022/0105A patent/JOP20220105A1/ar unknown
- 2022-05-11 US US17/742,169 patent/US20240002374A1/en active Pending
- 2022-05-12 CL CL2022001245A patent/CL2022001245A1/es unknown
- 2022-06-03 CO CONC2022/0007953A patent/CO2022007953A2/es unknown
- 2022-06-09 EC ECSENADI202246050A patent/ECSP22046050A/es unknown
-
2025
- 2025-07-30 JP JP2025126773A patent/JP2025160375A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023500408A5 (https=) | ||
| JP7721517B2 (ja) | Ｃｆｔｒ活性の欠損が介在する状態を治療するための５員ヘテロアリールアミノスルホンアミド | |
| JP2019513741A5 (https=) | ||
| JP2013508414A5 (https=) | ||
| JP2013513617A5 (https=) | ||
| RU2012129206A (ru) | Модуляторы атф-связывающих транспортеров | |
| ME02799B (me) | Modulatori ATP-vezujućih kasetnih transportera | |
| CN107207487B (zh) | 用于提高cftr活性的化合物、组合物和方法 | |
| KR102448404B1 (ko) | 규소 원자 함유 이바카프터 유사체 | |
| AU2020281069B2 (en) | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| JP2013532662A5 (https=) | ||
| JP2009522277A5 (https=) | ||
| JP2023519241A5 (https=) | ||
| HRP20160682T1 (hr) | Čvrsti oblici 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksiamido)-3-metilpiridin-2-il)benzojeve kiseline | |
| RU2014134456A (ru) | Препараты 3-(6-(1-(2, 2-дифторбензо[d][1, 3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты | |
| JP2013501787A5 (https=) | ||
| RU2012147272A (ru) | Фармацевтические композиции, включающие 3-(2, 2-дифторбензо[d][1, 3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойную кислоту, и их введение | |
| BR112013029240B1 (pt) | Composto derivado deuterado do ivacaftor, composição que o compreende e usos dos mesmos | |
| JP2011516420A5 (https=) | ||
| TW201920153A (zh) | 具有環狀構造的化合物 | |
| KR100652470B1 (ko) | 사이클로알킬 치환 아미노메틸피롤리딘 유도체 | |
| ES2238723T3 (es) | Derivados de aminociclopropano cis-sustituidos. | |
| CN109364075B (zh) | 氘化cftr增效剂 | |
| JP2003531158A (ja) | 化学療法または放射線療法により誘発される脱毛症の予防および治療方法 | |
| US20020077345A1 (en) | Cis-substituted aminocycloalkylpyrrolidine derivatives |